Abstract
Liquid biopsy has shown remarkably promising in oncology for the early diagnosis of cancer through the detection of circulating biomarkers such as circulating tumor cells (CTCs). Recent evidences suggest that CTCs represent effective prognostic and predictive biomarkers to monitor/predict therapy efficacy in breast, colon and prostate cancers [1,2]. However, the frequency of CTCs in blood is approximately 1 to 10 cells per 10 mL of blood, which is as challenging as looking for a needle in a haystack. In microfluidics, Digital Holography (DH) has been shown to be a promising technique to characterize CTCs with the aim to detect them inside a heterogeneous liquid sample. DH is label-free, real-time and gives access to the complex amplitude of the object [3-6]. Thus, any classification approach based on the holographic signature can exploit a reach information content to take a decision. Moreover, the flexible refocusing capability of DH imaging allows to inspect an entire liquid volume with a single capture. This enables the high-throughput inspection of blood and other bodily fluids rapidly flowing inside microfluidic channels.
© 2019 IEEE
PDF ArticleMore Like This
Natan T. Shaked
AM1I.3 CLEO: Applications and Technology (CLEO:A&T) 2019
Xi Zhu, Yuanzhen Suo, Nan Ding, Hao He, and Xunbin Wei
W3A.104 International Conference on Photonics and Imaging in Biology and Medicine (PIBM) 2017
Irina Vasilenko, Vladislav Metelin, Andrey Balkanov, and Pavel Ignatiev
11073_75 European Conference on Biomedical Optics (ECBO) 2019